Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad, AnaSpec

Premium
Bio-Rad Laboratories last week released a product application guide for the ProteOn XPR36 protein interaction array system. The guide describes four antibody characterization and development protocols for the system. The protocols are hybridoma screening and ranking, epitope mapping, kinetic analysis of antibody-antigen specificity, and determination of cross-reactivity of antibodies used in multiplex assays, the company said in a statement.
 

 
Last month AnaSpec introduced a series of peptides and antibodies. The peptides include protease-activated receptor-4; PAR-4 agonist; amide; human and AGA-(C8R) HNG17; and humanin derivative.
 
The antibodies include anti-MAP1-LC3 beta (NT) and anti-PTEN (pSer385).
 
The company also introduced the CEF control peptide pool, which had been previously available only individually. The peptide pool is a group of 32 peptides, 8 to 12 amino acids in length. Sequences are derived from the human cytomegalovirus, Epstein-Barr virus, and influenza virus.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.